246 related articles for article (PubMed ID: 30381640)
1. [Elucidation of a New Mechanism of Onset of Insulin Resistance: Effects of Statins and Tumor Necrosis Factor-α on Insulin Signal Transduction].
Takaguri A
Yakugaku Zasshi; 2018; 138(11):1329-1334. PubMed ID: 30381640
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the TNF-α-induced serine phosphorylation of IRS-1 at 636/639 by AICAR.
Shibata T; Takaguri A; Ichihara K; Satoh K
J Pharmacol Sci; 2013; 122(2):93-102. PubMed ID: 23698110
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
[TBL] [Abstract][Full Text] [Related]
4. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes.
Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Abe M; Shojima N; Fukushima Y; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2003 Mar; 17(3):487-97. PubMed ID: 12554784
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.
Hers I; Tavaré JM
Biochem J; 2005 Jun; 388(Pt 2):713-20. PubMed ID: 15713122
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
12. Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
Kong P; Chi R; Zhang L; Wang N; Lu Y
Fitoterapia; 2013 Dec; 91():44-50. PubMed ID: 23978582
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases.
Gao Z; Zuberi A; Quon MJ; Dong Z; Ye J
J Biol Chem; 2003 Jul; 278(27):24944-50. PubMed ID: 12714600
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1.
Kanety H; Feinstein R; Papa MZ; Hemi R; Karasik A
J Biol Chem; 1995 Oct; 270(40):23780-4. PubMed ID: 7559552
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance.
Vinayagamoorthi R; Bobby Z; Sridhar MG
J Endocrinol; 2008 May; 197(2):287-96. PubMed ID: 18434358
[TBL] [Abstract][Full Text] [Related]
18. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
19. Grape powder extract attenuates tumor necrosis factor α-mediated inflammation and insulin resistance in primary cultures of human adipocytes.
Chuang CC; Bumrungpert A; Kennedy A; Overman A; West T; Dawson B; McIntosh MK
J Nutr Biochem; 2011 Jan; 22(1):89-94. PubMed ID: 20382011
[TBL] [Abstract][Full Text] [Related]
20. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]